{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:42:20Z","timestamp":1791531740385,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872270, 81572683"],"award-info":[{"award-number":["81872270, 81572683"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602417"],"award-info":[{"award-number":["81602417"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012167","name":"National Science and Technology Infrastructure Program","doi-asserted-by":"crossref","award":["2017ZX10202203-004"],"award-info":[{"award-number":["2017ZX10202203-004"]}],"id":[{"id":"10.13039\/501100012167","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of CQ CSTC","doi-asserted-by":"crossref","award":["cstc2018jcyjAX0254"],"award-info":[{"award-number":["cstc2018jcyjAX0254"]}],"id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Program for Innovation Team of Higher Education in Chongqing","award":["CXTDX201601015"],"award-info":[{"award-number":["CXTDX201601015"]}]},{"name":"the Leading Talent Program of CQ CSTC","award":["CSTCCXLJRC201719"],"award-info":[{"award-number":["CSTCCXLJRC201719"]}]},{"name":"Natural Science Foundation Project of Chongqing","award":["cstc2019jcyj-msxmX0587"],"award-info":[{"award-number":["cstc2019jcyj-msxmX0587"]}]},{"name":"the Scientific Research Innovation Project for Postgraduate in Chongqing","award":["CYS19192"],"award-info":[{"award-number":["CYS19192"]}]},{"name":"the Scientific Research Innovation Project for Postgraduate in Chongqing","award":["CYS18207"],"award-info":[{"award-number":["CYS18207"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glutathione S-transferase zeta 1 (GSTZ1) is the penultimate enzyme in phenylalanine\/tyrosine catabolism. GSTZ1 is dysregulated in cancers; however, its role in tumorigenesis and progression of hepatocellular carcinoma (HCC) is largely unknown. We aimed to assess the role of GSTZ1 in HCC and to reveal the underlying mechanisms, which may contribute to finding a potential therapeutic strategy against HCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We first analyzed GSTZ1 expression levels in paired human HCC and adjacent normal tissue specimens and the prognostic effect of GSTZ1 on HCC patients. Thereafter, we evaluated the role of GSTZ1 in aerobic glycolysis in HCC cells on the basis of the oxygen consumption rate (OCR) and extracellular acidification rate (ECAR). Furthermore, we assessed the effect of GSTZ1 on HCC proliferation, glutathione (GSH) concentration, levels of reactive oxygen species (ROS), and nuclear factor erythroid 2-related factor 2 (NRF2) signaling via gain- and loss- of GSTZ1 function in vitro. Moreover, we investigated the effect of GSTZ1 on diethylnitrosamine (DEN) and carbon tetrachloride (CCl\n                      <jats:sub>4<\/jats:sub>\n                      ) induced hepatocarcinogenesis in a mouse model of HCC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      GSTZ1 was downregulated in HCC, thus indicating a poor prognosis. GSTZ1 deficiency significantly promoted hepatoma cell proliferation and aerobic glycolysis in HCC cells. Moreover, loss of GSTZ1 function depleted GSH, increased ROS levels, and enhanced lipid peroxidation, thus activating the NRF2-mediated antioxidant pathway. Furthermore,\n                      <jats:italic>Gstz1<\/jats:italic>\n                      knockout in mice promoted DEN\/CCl\n                      <jats:sub>4<\/jats:sub>\n                      -induced hepatocarcinogenesis via activation of the NRF2 signaling pathway. Furthermore, the antioxidant agent N-acetylcysteine and NRF2 inhibitor brusatol effectively suppressed the growth of\n                      <jats:italic>Gstz1<\/jats:italic>\n                      -knockout HepG2 cells and HCC progression in\n                      <jats:italic>Gstz1<\/jats:italic>\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>GSTZ1 serves as a tumor suppressor in HCC. GSH depletion caused by GSTZ1 deficiency elevates oxidative stress, thus constitutively activating the NRF2 antioxidant response pathway and accelerating HCC progression. Targeting the NRF2 signaling pathway may be a promising therapeutic approach for this subset of HCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-019-1459-6","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T19:03:14Z","timestamp":1572462194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1\/NRF2 pathway"],"prefix":"10.1186","volume":"38","author":[{"given":"Jingjing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiujie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,30]]},"reference":[{"issue":"7","key":"1459_CR1","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.molmed.2016.05.002","volume":"22","author":"S Menegon","year":"2016","unstructured":"Menegon S, Columbano A, Giordano S. The dual roles of NRF2 in Cancer. Trends Mol Med. 2016;22(7):578\u201393.","journal-title":"Trends Mol Med"},{"issue":"1","key":"1459_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/CCO.0b013e32835b651e","volume":"25","author":"P Hainaut","year":"2013","unstructured":"Hainaut P, Plymoth A. Hallmarks of Cancer: the next generation. Curr Opin Oncol. 2013;25(1):50\u20131.","journal-title":"Curr Opin Oncol"},{"issue":"2","key":"1459_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jcmgh.2017.05.004","volume":"4","author":"ZC Nwosu","year":"2017","unstructured":"Nwosu ZC, Megger DA, Hammad S, et al. Identification of the consistently altered metabolic targets in human hepatocellular carcinoma. Cell Mol Gastroenterol Hepatol. 2017;4(2):303\u2013323.e1.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"9","key":"1459_CR4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrd3504","volume":"10","author":"HMG Vander","year":"2011","unstructured":"Vander HMG. Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov. 2011;10(9):671\u201384.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"1459_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1074\/jbc.273.1.329","volume":"273","author":"JM Fern\u00e1ndez-Ca\u00f1\u00f3n","year":"1998","unstructured":"Fern\u00e1ndez-Ca\u00f1\u00f3n JM, Pe\u00f1alva MA. Characterization of a fungal maleylacetoacetate isomerase gene and identification of its human homologue. J Biol Chem. 1998;273(1):329\u201337.","journal-title":"J Biol Chem"},{"issue":"1","key":"1459_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41389-017-0025-3","volume":"7","author":"N Allocati","year":"2018","unstructured":"Allocati N, Masulli M, Di IC, Federici L. Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases. Oncogenesis. 2018;7(1):8.","journal-title":"Oncogenesis."},{"issue":"Pt 2","key":"1459_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1042\/bj3310371","volume":"331","author":"Z Tong","year":"1998","unstructured":"Tong Z, Board PG, Anders MW. Glutathione transferase zeta catalyses the oxygenation of the carcinogen dichloroacetic acid to glyoxylic acid. Biochem J. 1998;331(Pt 2):371\u20134.","journal-title":"Biochem J"},{"key":"1459_CR8","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.1128\/MCB.22.13.4943-4951.2002","volume":"22","author":"JM Fern\u00e1ndez-Ca\u00f1\u00f3n","year":"2002","unstructured":"Fern\u00e1ndez-Ca\u00f1\u00f3n JM, Baetscher MW, Finegold M, Burlingame T, Gibson KM, Grompe M. Maleylacetoacetate isomerase (MAAI\/GSTZ)-deficient mice reveal a glutathione-dependent nonenzymatic bypass in tyrosine catabolism. Mol Cell Biol. 2002;22:4943\u201351.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"1459_CR9","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.bbagen.2016.01.024","volume":"1860","author":"SC Jahn","year":"2016","unstructured":"Jahn SC, Solayman MH, Lorenzo RJ, Langaee T, Stacpoole PW, James MO. GSTZ1 expression and chloride concentrations modulate sensitivity of cancer cells to dichloroacetate. Biochim Biophys Acta. 2016;1860(6):1202\u201310.","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"1459_CR10","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrd4002","volume":"12","author":"C Gorrini","year":"2013","unstructured":"Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12(12):931\u201347.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"1459_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","volume":"34","author":"MR de la Vega","year":"2018","unstructured":"de la Vega MR, Chapman E, Zhang DD. NRF2 and the hallmarks of Cancer. Cancer Cell. 2018;34(1):21\u201343.","journal-title":"Cancer Cell"},{"key":"1459_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.biocel.2015.06.017","volume":"65","author":"AJ Hayes","year":"2015","unstructured":"Hayes AJ, Skouras C, Haugk B, Charnley RM. Keap1-Nrf2 signalling in pancreatic cancer. Int J Biochem Cell Biol. 2015;65:288\u201399.","journal-title":"Int J Biochem Cell Biol"},{"issue":"Pt 2","key":"1459_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1042\/bj20030754","volume":"374","author":"P Nioi","year":"2003","unstructured":"Nioi P, McMahon M, Itoh K, Yamamoto M, Hayes JD. Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. Biochem J. 2003;374(Pt 2):337\u201348.","journal-title":"Biochem J"},{"key":"1459_CR14","doi-asserted-by":"crossref","unstructured":"Yang F, Li J, Deng H, Wang Y, Lei C, Wang Q, et al. GSTZ1-1 Deficiency Activates NRF2\/IGF1R Axis in HCC via Accumulation of Oncometabolite Succinylacetone. EMBO J. 2019;38(15):e101964.","DOI":"10.15252\/embj.2019101964"},{"key":"1459_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/carcin\/20.1.59","volume":"20","author":"G Shiota","year":"1999","unstructured":"Shiota G, Harada K, Ishida M, Tomie Y, Okubo M, Katayama S, Ito H, Kawasaki H. Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine-treated mice. Carcinogenesis. 1999;20:59\u201363.","journal-title":"Carcinogenesis."},{"issue":"6","key":"1459_CR16","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nmeth.1212","volume":"5","author":"M Gutscher","year":"2008","unstructured":"Gutscher M, Pauleau AL, Marty L, et al. Real-time imaging of the intracellular glutathione redox potential. Nat Methods. 2008;5(6):553\u20139.","journal-title":"Nat Methods"},{"issue":"11","key":"1459_CR17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrc3803","volume":"14","author":"SS Sabharwal","year":"2014","unstructured":"Sabharwal SS, Schumacker PT. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles\u2019 heel. Nat Rev Cancer. 2014;14(11):709\u201321.","journal-title":"Nat Rev Cancer"},{"key":"1459_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.redox.2014.12.011","volume":"4","author":"H Zhong","year":"2015","unstructured":"Zhong H, Yin H. Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: focusing on mitochondria. Redox Biol. 2015;4:193\u20139.","journal-title":"Redox Biol"},{"issue":"4596","key":"1459_CR19","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1126\/science.6836290","volume":"220","author":"A Meister","year":"1983","unstructured":"Meister A. Selective modification of glutathione metabolism. Science. 1983;220(4596):472\u20137.","journal-title":"Science."},{"key":"1459_CR20","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1124\/mol.105.018911","volume":"69","author":"AC Blackburn","year":"2006","unstructured":"Blackburn AC, Matthaei KI, Lim C, Taylor MC, Cappello JY, Hayes JD, Anders MW, Board PG. Deficiency of glutathione transferase zeta causes oxidative stress and activation of antioxidant response pathways. Mol Pharmacol. 2006;69:650\u20137.","journal-title":"Mol Pharmacol"},{"issue":"1","key":"1459_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/MCO.0b013e32833383af","volume":"13","author":"P Tessari","year":"2010","unstructured":"Tessari P, Vettore M, Millioni R, Puricelli L, Orlando R. Effect of liver cirrhosis on phenylalanine and tyrosine metabolism. Curr Opin Clin Nutr Metab Care. 2010;13(1):81\u20136.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1459_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/978-3-642-15720-2_18","volume-title":"Inborn Metabolic Diseases","author":"A Chakrapani","year":"2012","unstructured":"Chakrapani A, Gissen P, McKiernan P. Disorders of tyrosine metabolism. In: Inborn Metabolic Diseases. Berlin, Heidelberg: Springer; 2012. p. 265\u20136."},{"issue":"5","key":"1459_CR23","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1002\/hep.1840200513","volume":"20","author":"FJ van Spronsen","year":"1994","unstructured":"van Spronsen FJ, Thomasse Y, Smit GP, et al. Hereditary tyrosinemia type I: a new clinical classification with difference in prognosis on dietary treatment. Hepatology. 1994;20(5):1187\u201391.","journal-title":"Hepatology."},{"issue":"3","key":"1459_CR24","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S0022-3476(76)80259-4","volume":"88","author":"AG Weinberg","year":"1976","unstructured":"Weinberg AG, Mize CE, Worthen HG. The occurrence of hepatoma in the chronic form of hereditary tyrosinemia. J Pediatr. 1976;88(3):434\u20138.","journal-title":"J Pediatr"},{"issue":"4","key":"1459_CR25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/jmedgenet-2016-104289","volume":"54","author":"H Yang","year":"2017","unstructured":"Yang H, Al-Hertani W, Cyr D, et al. Hypersuccinylacetonaemia and normal liver function in maleylacetoacetate isomerase deficiency. J Med Genet. 2017;54(4):241\u20137.","journal-title":"J Med Genet"},{"key":"1459_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.trecan.2018.11.003","volume":"5","author":"Z Wang","year":"2019","unstructured":"Wang Z, Dong C. Gluconeogenesis in Cancer: function and regulation of PEPCK, FBPase, and G6Pase. Trends Cancer. 2019;5:30\u201345.","journal-title":"Trends Cancer"},{"key":"1459_CR27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/bcr332","volume":"3","author":"RA Smith","year":"2001","unstructured":"Smith RA, Curran JE, Weinstein SR, Griffiths LR. Investigation of glutathione S-transferase zeta and the development of sporadic breast cancer. Breast Cancer Res. 2001;3:409\u201311.","journal-title":"Breast Cancer Res"},{"key":"1459_CR28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10549-009-0589-5","volume":"121","author":"IE Andonova","year":"2010","unstructured":"Andonova IE, Justenhoven C, Winter S, Hamann U, Baisch C, Rabstein S, Spickenheuer A, Harth V, Pesch B, Br\u00fcning T, et al. No evidence for glutathione S-transferases GSTA2, GSTM2, GSTO1, GSTO2, and GSTZ1 in breast cancer risk. Breast Cancer Res Treat. 2010;121:497\u2013502.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"1459_CR29","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0002-9440(10)63332-9","volume":"165","author":"CE Lim","year":"2004","unstructured":"Lim CE, Matthaei KI, Blackburn AC, et al. Mice deficient in glutathione transferase zeta\/maleylacetoacetate isomerase exhibit a range of pathological changes and elevated expression of alpha, mu, and pi class glutathione transferases. Am J Pathol. 2004;165(2):679\u201393.","journal-title":"Am J Pathol"},{"issue":"3","key":"1459_CR30","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ymgme.2007.09.018","volume":"93","author":"C Langlois","year":"2008","unstructured":"Langlois C, Jorquera R, Orejuela D, et al. Rescue from neonatal death in the murine model of hereditary tyrosinemia by glutathione monoethylester and vitamin C treatment. Mol Genet Metab. 2008;93(3):306\u201313.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"1459_CR31","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ccr.2011.09.006","volume":"20","author":"J Adam","year":"2011","unstructured":"Adam J, Hatipoglu E, O'Flaherty L, et al. Renal cyst formation in Fh1-deficient mice is independent of the Hif\/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell. 2011;20(4):524\u201337.","journal-title":"Cancer Cell"},{"issue":"2","key":"1459_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.drup.2004.01.004","volume":"7","author":"H Pelicano","year":"2004","unstructured":"Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat. 2004;7(2):97\u2013110.","journal-title":"Drug Resist Updat"},{"key":"1459_CR33","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.freeradbiomed.2016.12.025","volume":"111","author":"F Gu\u00e9raud","year":"2017","unstructured":"Gu\u00e9raud F. 4-Hydroxynonenal metabolites and adducts in pre-carcinogenic conditions and cancer. Free Radic Biol Med. 2017;111:196\u2013208.","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"1459_CR34","doi-asserted-by":"publisher","first-page":"e2253","DOI":"10.1038\/cddis.2016.105","volume":"7","author":"E Panieri","year":"2016","unstructured":"Panieri E, Santoro MM. ROS homeostasis and metabolism: a dangerous liason in cancer cells. Cell Death Dis. 2016;7(6):e2253.","journal-title":"Cell Death Dis"},{"key":"1459_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrc2981","volume":"11","author":"RA Cairns","year":"2011","unstructured":"Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11:85\u201395.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"1459_CR36","doi-asserted-by":"publisher","first-page":"8463","DOI":"10.1074\/jbc.M109.051714","volume":"285","author":"S Fourquet","year":"2010","unstructured":"Fourquet S, Guerois R, Biard D, Toledano MB. Activation of NRF2 by nitrosative agents and H2O2 involves KEAP1 disulfide formation. J Biol Chem. 2010;285(11):8463\u201371.","journal-title":"J Biol Chem"},{"issue":"8","key":"1459_CR37","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nrc3278","volume":"12","author":"MB Sporn","year":"2012","unstructured":"Sporn MB, Liby KT. NRF2 and cancer: the good, the bad and the importance of context. Nat Rev Cancer. 2012;12(8):564\u201371.","journal-title":"Nat Rev Cancer"},{"key":"1459_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1517\/17425250903427980","volume":"6","author":"PG Di","year":"2010","unstructured":"Di PG, Magno LA, Rios-Santos F. Glutathione S-transferases: an overview in cancer research. Expert Opin Drug Metab Toxicol. 2010;6:153\u201370.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1459_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF00689804","volume":"12","author":"M Belinsky","year":"1993","unstructured":"Belinsky M, Jaiswal AK. NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues. Cancer Metastasis Rev. 1993;12:103\u201317.","journal-title":"Cancer Metastasis Rev"},{"key":"1459_CR40","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1128\/MCB.00483-09","volume":"29","author":"S Sudarshan","year":"2009","unstructured":"Sudarshan S, Sourbier C, Kong HS, Block K, Valera RVA, Yang Y, Galindo C, Mollapour M, Scroggins B, Goode N, et al. Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species. Mol Cell Biol. 2009;29:4080\u201390.","journal-title":"Mol Cell Biol"},{"key":"1459_CR41","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ccr.2011.08.024","volume":"20","author":"A Ooi","year":"2011","unstructured":"Ooi A, Wong JC, Petillo D, Roossien D, Perrier-Trudova V, Whitten D, Min BW, Tan MH, Zhang Z, Yang XJ, et al. An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell. 2011;20:511\u201323.","journal-title":"Cancer Cell"},{"key":"1459_CR42","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","volume":"236","author":"K Itoh","year":"1997","unstructured":"Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, et al. An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997;236:313\u201322.","journal-title":"Biochem Biophys Res Commun"},{"key":"1459_CR43","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.redox.2018.05.002","volume":"17","author":"A Raghunath","year":"2018","unstructured":"Raghunath A, Sundarraj K, Nagarajan R, Arfuso F, Bian J, Kumar AP, Sethi G, Perumal E. Antioxidant response elements: discovery, classes, regulation and potential applications. Redox Biol. 2018;17:297\u2013314.","journal-title":"Redox Biol"},{"key":"1459_CR44","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1089\/ars.2017.7342","volume":"29","author":"C Tonelli","year":"2018","unstructured":"Tonelli C, IIC C, Tuveson DA. Transcriptional regulation by Nrf2. Antioxid Redox Signal. 2018;29:1727\u201345.","journal-title":"Antioxid Redox Signal"},{"key":"1459_CR45","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/hep.22391","volume":"48","author":"S Marhenke","year":"2008","unstructured":"Marhenke S, Laml\u00e9 J, Buitrago-Molina LE, Ca\u00f1\u00f3n JM, Geffers R, Finegold M, Sporn M, Yamamoto M, Manns MP, Grompe M, et al. Activation of nuclear factor E2-related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development. Hepatology. 2008;48:487\u201396.","journal-title":"Hepatology."},{"issue":"Suppl","key":"1459_CR46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng1089","volume":"33","author":"R Jaenisch","year":"2003","unstructured":"Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33(Suppl):245\u201354.","journal-title":"Nat Genet"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1459-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-019-1459-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1459-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T20:28:50Z","timestamp":1603916930000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-019-1459-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,30]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1459"],"URL":"https:\/\/doi.org\/10.1186\/s13046-019-1459-6","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,30]]},"assertion":[{"value":"14 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients were provided informed consent, and this study was conducted with the approval of Institutional Ethical Review Board of Chongqing Medical University (project license number: 2017012). All animal experiments were conducted according to the guidelines of the Institutional Animal Care and Use Committee at Chongqing Medical University (The project license number: 2017012), and protocols of animal care and use adhere to National Regulations of the administration of laboratory animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All contributing authors agree to the publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"438"}}